Editas Medicine Names Andrew Hirsch to Board of Directors
May 31, 2017 16:01 ET
|
Editas Medicine
CAMBRIDGE, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment of Andrew Hirsch to its board of directors,...